Knowledge & perceptions

Associations between noticing public health education campaigns about cannabis and risk perceptions in the northern Canadian territories: a cross sectional study.

Schwartz N, Poon T, Hammond D, Hobin E. Health Education Research 2024; Jun 21:cyae021. DOI: 10.1093/her/cyae021. Epub ahead of print.

Canada’s THC Unit: Applications for the Legal Cannabis Market.

Wood S, Gabrys R, Freeman T, Hammond D. Canada’s THC Unit: Applications for the Legal Cannabis Market. International Journal of Drug Policy 2024; 128: 104457.

Cannabidiol-only product use in Pregnancy in the United States and Canada: Findings from the International Cannabis Policy Study.

Bhatia D, Sakai J, Reddy S, Mikulich S, Hammond D. Obstetrics & Gynecology 2024; In press.

Social norms for cannabis use following non-medical legalization in Canada.

Winfield-Ward L, Hammond D. American Journal of Preventive Medicine 2023; S0749-3797(23)00513-5.

Consumer perceptions of legal cannabis products in Canada, 2019-2021: A repeat cross-sectional study.

Wadsworth E, Fataar F, Goodman S, Smith D, Renard J, Gabrys R, Jesseman R, Hammond D. BMC Public Health 2022; 22(1):2048.

THC labelling on cannabis products: An experimental study of approaches for labelling THC servings on cannabis.

Goodman S, Hammond D. Journal of Cannabis Research 2022; 4(1):17.

Prices and purchase sources for dried cannabis flower in the United States, 2019-2020.

Wadsworth E, Driezen P, Pacula RL, Kilmer B, Hammond D. Cannabis and Cannabinoid Research 2022; 8(5):923-932.

Perceptions of the health risks of cannabis: estimates from national surveys in Canada and the United States, 2018-2019.

Goodman S, Hammond D. Health Education Research 2022; 37(2):61-78.

Self-reported THC content and associations with perceptions of feeling high among cannabis consumers.

Lineham J, Wadsworth E, Hammond D.Drug and Alcohol Review 2023; 42(5):1142-1152.

Use and perceptions of cannabidiol (CBD) products in Canada and the USA.

Goodman S, Wadsworth E, Schauer G, Hammond D. Cannabis and Cannabinoid Research 2022; 7(3):355-364.

Do mandatory health warnings labels on consumer products increase recall of the health risks of cannabis?

Goodman S, Leos-Toro C, Hammond D. Substance Use & Misuse 2022;57(4):569-580.

Noticing of cannabis health warning labels in Canada and the US.

Goodman S, Hammond D. Health Promotion and Chronic Disease Prevention in Canada: Research, Policy and Practice 2021; 41(7/8):201-210.

Cannabis use and driving under the influence: behaviors and attitudes by state-level legal sale of recreational cannabis.

Lensch T, Sloan K, Ausmus J, Pearson J, Clements-Nolle K, Goodman S, Hammond D. Preventive Medicine 2020; 141:106320

Knowledge of tetrahydrocannabinol and cannabidiol levels among cannabis consumers in the United States and Canada.

Hammond D, Goodman S. Cannabis and Cannabinoid Research 2020; 7(3):345-354.

Consumer perceptions of ‘legal’ and ‘illegal’ cannabis in US states with legal cannabis sales.

Fataar F, Goodman S, Wadsworth E, Hammond D. Addictive Behaviors 2020; 112:106563.

Does unit-dose packaging influence understanding of serving size information for cannabis edibles?

Goodman S, Hammond D. Journal of Studies on Alcohol & Drugs 2020;81(2):173-179.

The impact of plain packaging and health warnings on consumer appeal of cannabis products.

Goodman S, Leos-Toro C, Hammond D. Drug and Alcohol Dependence 2019; Dec 1; 205:107633.